SMA
MCID: SPN046

Spinal Muscular Atrophy malady

Summaries for Spinal Muscular Atrophy

Sources:
6Disease Ontology, 30NIH Rare Diseases, 23MedlinePlus, 15GeneReviews, 17Genetics Home Reference, 44Wikipedia, 22MalaCards
See all sources

Export this MalaCard
NINDS: Spinal Muscular Atrophy (SMA) Types I, II, and III belong to a group of hereditary diseases that cause weakness and wasting of the voluntary muscles in the arms and legs of infants and children. The disorders are caused by an abnormal or missing gene known as the survival motor neuron gene 1 (SMN1), which is responsible for the production of a protein essential to motor neurons. Without this protein, lower motor neurons in the spinal cord degenerate and die. The type of SMA (I, II, or III) is determined by the age of onset and the severity of symptoms. Type I (also known as Werdnig-Hoffman disease, or infantile-onset SMA) is evident at birth or within the first few months. Symptoms include floppy limbs and trunk, feeble movements of the arms and legs, swallowing and feeding difficulties, and impaired breathing. Type II (the intermediate form) usually begins 6 and 18 months of age. Legs tend to be more impaired than arms. Children with Type II may able to sit and some may be able to stand or walk with help. Symptoms of Type III (also called Kugelberg-Welander disease) appear between 2 and 17 years of age and include difficulty running, climbing steps, or rising from a chair. 31

MalaCards: Spinal Muscular Atrophy, also known as progressive muscular atrophy, is related to proximal spinal muscular atrophy and juvenile spinal muscular atrophy. An important gene associated with Spinal Muscular Atrophy is SMN1 (survival of motor neuron 1, telomeric), and among its related pathways are mRNA Processing and mRNA Decay by 5 to 3 Exoribonuclease. The compounds nsc34 and h2o2 have been mentioned in the context of this disorder. Affiliated tissues include brain, spinal cord and heart, and related mouse phenotypes are respiratory system and adipose tissue.

Disease Ontology: A motor neuron disease that is a degenerative neuromuscular disease characterized by motor neuron degeration.6

NIH Rare Diseases: Spinal muscular atrophy is a group of inherited disorders that cause progressive muscle degeneration and weakness. It is caused by a loss of specialized nerve cells, called motor neurons, in the spinal cord and the part of the brain that is connected to the spinal cord (the brainstem). The loss of motor neurons leads to weakness and wasting (atrophy) of muscles used for activities such as crawling, walking, sitting up, and controlling head movement. In severe cases, the muscles used for breathing and swallowing are affected. Spinal muscular atrophy is divided into subtypes based on the severity of the disease and the age when symptoms first appear. It is usually inherited as an autosomal recessive trait.30

MedlinePlus: Spinal muscular atrophy (sma) is a genetic disease that attacks nerve cells, called motor neurons, in your spinal cord. these neurons communicate with your voluntary muscles - the ones you can control, like in your arms and legs. as you lose the neurons, your muscles weaken. this can affect walking, crawling, breathing, swallowing and head and neck control. sma runs in families. parents usually have no symptoms, but still carry the gene. genetic counseling is important if the disease runs in your family. there are many types of sma, and some of them are fatal. life expectancy depends on the type you have and how it affects your breathing. there is no cure. medicines and physical therapy help treat symptoms. nih: national institute of neurological disorders and stroke23

Genetics Home Reference: Spinal muscular atrophy is a disorder that affects the control of muscle movement. It is caused by a loss of specialized nerve cells, called motor neurons, in the spinal cord and the part of the brain that is connected to the spinal cord (the brainstem). The loss of motor neurons leads to weakness and wasting (atrophy) of muscles used for activities such as crawling, walking, sitting up, and controlling head movement. In severe cases of spinal muscular atrophy, the muscles used for breathing and swallowing are affected. Spinal muscular atrophy is divided into subtypes based on the severity of the disease and the age when symptoms appear.17

Wikipedia: Spinal muscular atrophy (SMA) is an autosomal recessive disease caused by a genetic defect in the SMN1...44 more...

GeneReviews summary for sma

Aliases & Descriptions for Spinal Muscular Atrophy

Sources:
44Wikipedia, 17Genetics Home Reference, 43UMLS, 6Disease Ontology, 7diseasecard, 15GeneReviews, 30NIH Rare Diseases, 16GeneTests, 31NINDS, 8DISEASES, 23MedlinePlus, 32Novoseek , 40SNOMED-CT, 19ICD9CM, 24MeSH, 27NCIt
See all sources

Aliases & Descriptions:

spinal muscular atrophy 6 7 44 15 30 16 17 31 8 23 43
progressive muscular atrophy 44 17 43
sma 44 16 17
hereditary motor neuronopathy 44 17
muscular atrophy spinal 32
muscular atrophy 43
smn 16

External Ids:

ICD9CM19 335.10, 335.1

Related Diseases for Spinal Muscular Atrophy

Sources:
13GeneCards, 14GeneDecks
See all sources

Disease types for spinal muscular atrophy family:

spinal muscular atrophy 1 spinal muscular atrophy type 2
spinal muscular atrophy (smn1) spinal muscular atrophy (smn2)

Diseases related to spinal muscular atrophy by text searches and GeneDecks gene sharing:

(show top 50)    (show all 281)
idRelated DiseaseScoreTop Affiliating Genes
1proximal spinal muscular atrophy36.2NAIP, LMNA, VAPB, CHKB, APOE, MAP1B
2juvenile spinal muscular atrophy36.2NAIP, CHKB, SMN1, SMN2
3spinal muscular atrophy 135.1VRK1, NAIP, SCO2, GTF2H2, MAP1B, SMN1
4motor neuronopathy34.8ATP7A, AR, IGHMBP2, HSPB8, PLEKHG5
5spinal muscular atrophy type 234.2NCAM1, NAIP, SMN1, SMN2
6progressive muscular atrophy33.8TRPV4, SMN1, DPP6
7lower motor neuron disease32.4SMN1, SMN2, SOD1
8spinal cord disease31.5NAIP, IGHMBP2, DDX20, SMN1, SMN2
9charcot-marie-tooth neuropathy31.0LMNA, MTM1, HSPB8, TRPV4, GARS
10charcot-marie-tooth disease type 230.6LMNA, HSPB8, TRPV4, DYNC1H1, GARS
11tooth disease30.0LMNA, MTM1, HSPB8, TRPV4, DYNC1H1, NDUFS4
12charcot-marie-tooth disease30.0LMNA, MTM1, HSPB8, TRPV4, DYNC1H1, NDUFS4
13x-linked spinal-bulbar muscle atrophy29.9AR, CASP3, SOD1
14motor neuron disease29.4BSCL2, NAIP, VAPB, AR, APOE, DDX20
15neuromuscular disease29.4NCAM1, NAIP, LMNA, CHKB, MTM1, AR
16cytoplasmic body myopathy29.4CHKB, DMD, SMN1
17inclusion body myositis28.3LMNA, BCL2, BCL2L1, CHKB, APOE, SNCA
18protein s deficiency28.3LMNA, BLZF1, APOE, CASP3, GM2A, TP53
19muscular dystrophy27.6NCAM1, LMNA, BCL2, CHKB, AR, HSPG2
20lateral sclerosis27.5NAIP, VAPB, BCL2, BCL2L1, SCO2, CHKB
21systemic lupus erythematosus27.2BLZF1, FBL, HSPG2, SNRPN, SNRPD1, CREB1
22differentiating neuroblastoma27.1BCL2, HSPG2, TP53, SNCA, SMN1, CREB1
23muscular atrophy26.9ZNF259, NCAM1, VRK1, SERF1A, SERF1B, SERF2
24amyotrophic lateral sclerosis26.8NAIP, VAPB, BCL2, BCL2L1, SCO2, CHKB
25myotonic dystrophy26.3LMNA, BCL2, CHKB, MTM1, CFL1, AR
26myasthenia gravis26.1NCAM1, BCL2, CHKB, AR, APOE, HSPG2
27myositis26.1NCAM1, LMNA, BCL2, BCL2L1, CHKB, FBL
28neuropathy24.8NCAM1, BSCL2, NAIP, LMNA, PARP1, SCO2
29neurodegenerative disease24.7NCAM1, NAIP, BLZF1, PARP1, BCL2, BCL2L1
30myopathy24.5NCAM1, BSCL2, LMNA, BLZF1, BCL2, CHKB
31lung carcinoma24.2NCAM1, LMNA, BIRC2, PARP1, BCL2, BCL2L1
32fibrosis23.9LMNA, BCL2, BCL2L1, GTF2H2, MECP2, FBL
33neuronitis23.5ZNF259, NCAM1, BSCL2, NAIP, LMNA, VAPB
34lupus erythematosus23.0BLZF1, PARP1, BCL2, CHKB, AR, MECP2
35neurodegeneration22.9ZNF259, BSCL2, NAIP, BLZF1, KHSRP, PARP1
36neuroblastoma22.8NCAM1, LMNA, BLZF1, KHSRP, PARP1, BCL2
37ataxia22.1SERF2, BLZF1, BIRC2, KHSRP, PARP1, BCL2
38pancreatic cancer21.9NCAM1, BLZF1, BIRC2, KHDRBS1, PARP1, BCL2
39hepatitis21.6NCAM1, VRK1, BSCL2, NAIP, LMNA, VAPB
40sarcoma20.6NCAM1, BLZF1, PARP1, BCL2, BCL2L1, CHKB
41prostatitis20.1NCAM1, NAIP, LMNA, BLZF1, BIRC2, KHDRBS1
42cerebritis19.9NCAM1, LMNA, BLZF1, PARP1, BCL2, BCL2L1
43carcinoma18.0NCAM1, VRK1, LMNA, BLZF1, BIRC2, KHDRBS1
44tay-sachs disease13.9GM2A, SMN1, HEXA
45mixed connective tissue disease13.4HSPG2, SNRPN, SNRPD3, RNPC3, LSM2
46connective tissue disease13.2ATP7A, FBL, HSPG2, RNPC3, TOP1
47spinocerebellar ataxia type 313.2BLZF1, AR, APOE, SNCA, TARDBP, SLC1A3
48aicardi-goutieres syndrome13.1SCO2, MECP2, SNCA, COX5A, NDUFS4, TK2
49corticobasal degeneration13.0CFL1, CASP3, SNCA, TARDBP
50prion disease13.0BLZF1, APOE, SNCA, CREB1, COX5A, SLC1A3

Graphical network of the top 20 diseases related to spinal muscular atrophy:



Graphical network of diseases related to spinal muscular atrophy

Clinical Features for Spinal Muscular Atrophy

Drugs & Therapeutics for Spinal Muscular Atrophy

Sources:
4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials, 21LifeMap Discovery™, 43UMLS, 28NDF-RT
See all sources

Approved drugs:

Search CenterWatch for spinal muscular atrophy

Drug clinical trials:

Search ClinicalTrials for spinal muscular atrophy

Search NIH Clinical Center for spinal muscular atrophy

Search CenterWatch for spinal muscular atrophy

Cell-based therapeutics:


LifeMap Discovery
The database of embryonic development, stem cell research and regenerative medicine
Stem-Cell-Based therapeutic approaches for spinal muscular atrophy:
Neural stem cell-derived motoneuron transplantation in SMARD1 mice
Embryonic/Adult Cultured Cells Related to spinal muscular atrophy:
Motor neuron progenitors, PMIDs: 19776263

Genetic Tests for Spinal Muscular Atrophy

Anatomical Context for Spinal Muscular Atrophy

Sources:
21LifeMap Discovery™, 22MalaCards
See all sources

MalaCards organs/tissues related to spinal muscular atrophy:

22
Brain, Spinal cord, Heart, Skeletal muscle, T cells, B cells

LifeMap Discovery
The database of embryonic development, stem cell research and regenerative medicine

Embryonic and adult cells/anatomical compartments related to spinal muscular atrophy:
id Organ / Tissue -> Anatomical Compartment -> Cell Relevance
1 Spinal Cord -> Motor Neural Progenitor Domain -> Motor Neural Progenitor Cells Potential therapeutic candidate
2 Spinal Cord -> Motor Neural Progenitor Domain -> Motor Neurons Potential therapeutic candidate, affected by disease

Phenotypes for genes affiliated with Spinal Muscular Atrophy

Sources:
25MGI
See all sources

Publications for genes affiliated with Spinal Muscular Atrophy

Sources:
35PubMed
See all sources

Articles related to spinal muscular atrophy:

(show top 50)    (show all 351)
idTitleAuthorsYearAffiliating Genes
1Deletion analysis of SMN1 exon 7 alone may be necessa ry and sufficient for the diagnosis of spinal muscular atrophy. (21338334)Sasongko T.H.... Zabidi-Hussin Z.2011SMN1
2Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model. (21979052)Hua Y.... Krainer A.R.2011SMN2
3Spinal muscular atrophy: a timely review. (21482919)Kolb S.J.... Kissel J.T.2011SMN1
4Rapid diagnosis of spinal muscular atrophy using tetr a-primer ARMS PCR assay: simultaneous detection of SMN1 and SMN2 deletion. (20025960)Baris I.... Arican-Baris S.T.2010SMN1, SMN2
5Scapuloperoneal spinal muscular atrophy and CMT2C are allelic disorders caused by alterations in TRPV4. (20037587)Deng H.X.... Siddique T.2010TRPV4
6In vivo NMDA receptor activation accelerates motor un it maturation, protects spinal motor neurons, and enhances SMN2 gene expression in severe spinal muscular atrophy mice. (20739549)Biondi O.... Charbonnier F.2010SMN2
7Universal multiplex PCR and CE for quantification of SMN1/SMN2 genes in spinal muscular atrophy. (19373809)Wang C.C.... Wu S.M.2009SMN1, SMN2
8A short antisense oligonucleotide masking a unique in tronic motif prevents skipping of a critical exon in spinal muscular atrophy. (19430205)Singh N.N.... Singh R.N.2009GEMIN2
9Deletions in the survival motor neuron gene in Iranian patients with spinal muscular atrophy. (19271042)Hasanzad M.... Najmabadi H.2009SMN1, SMN2
10Histone deacetylase inhibition activity and molecular docking of (e )-resveratrol: its therapeutic potential in spinal muscular atrophy. (19207472)DayangaAs-Erden D.... Erdem-Yurter H.2009SMN1, SMN2
11Phenotype modifiers of spinal muscular atrophy: the number of SMN2 gene copies, deletion in the NAIP gene and probably gender influence the course of the disease. (19287802)Jedrzejowska M.... Hausmanowa-Petrusewicz I.2009SMN1, SMN2, NAIP
12Tetracyclines that promote SMN2 exon 7 splicing as th erapeutics for spinal muscular atrophy. (20161659)Hastings M.L.... Krainer A.R.2009SMN1, SMN2
13Congenital heart defects in spinal muscular atrophy type I: a clinical report of two siblings and a review of the literature. (18266240)Menke L.A.... Cobben J.M.2008SMN1
14Genetic carrier screening for spinal muscular atrophy and spinal muscular atrophy with respiratory distress 1 in an isolated population in Israel. (18298318)Basel-Vanagaite L.... Shohat M.2008IGHMBP2
15Quantitative analysis of SMN1 and SMN2 genes based on DHPLC: a reliable method for detection of non-homozygous patients with spinal muscular atrophy (18844099)Long M.J.... Huang S.Z.2008SMN1, SMN2
16Nonsense-mediated messenger RNA decay of survival motor neuron 1 causes spinal muscular atrophy. (18172693)Brichta L.... Wirth B.2008SMN1
17Congenital heart disease is a feature of severe infantile spinal muscular atrophy. (18662980)Rudnik-Schoneborn S.... Zerres K.2008SMN1, SMN2
18A newborn with spinal muscular atrophy type 0 presenting with a clinicopathological picture suggestive of myotubular myopathy. (18006961)Nadeau A.... Vanasse M.2007MTM1
19Molecular analysis and prenatal prediction of spinal muscular atrophy in Chinese patients by the combination of restriction fragment length polymorphism analysis, denaturing high-performance liquid chromatography, and linkage analysis. (17296838)Chen W.J.... Wang N.2007SMN1
20Congenital bone fractures in spinal muscular atrophy: functional role for SMN protein in bone remodeling. (17761651)Shanmugarajan S.... Reddy S.V.2007SMN1
21Mutations of the LMNA gene can mimic autosomal dominant proximal spinal muscular atrophy. (17136397)Rudnik-Schoeneborn S.... Zerres K.2007LMNA
22Molecular analysis of the SMN1 and NAIP genes in Iranian patients with spinal muscular atrophy. (18071605)Derakhshandeh-Peykar P.... Farhud D.D.2007SMN1, NAIP
23Molecular mechanisms of spinal muscular atrophy. (17761653)Sumner C.J.2007SMN2
24Correlation between deletion patterns of SMN and NAIP genes and the clinical features of spinal muscular atrophy in Indian patients. (16936383)Dastur R.S.... Nadkarni J.J.2006SMN1, NAIP, LOC647859
25Detection of spinal muscular atrophy carriers by nest ed polymerase chain reaction of single sperm cells. (16544998)Yaron Y.... Malcov M.2006SMN1
26Application of a rapid non-invasive technique in the molecular diagnosis of spinal muscular atrophy (SMA). (15871052)Jedrzejowska M.... Hausmanowa-Petrusewicz I.2005SMN1
27A new locus for recessive distal spinal muscular atrophy at Xq13.1-q21. (14985388)Takata R.I.... Zatz M.2004ATP7A
28Spinal muscular atrophies in the adult (15034481)Camu W.2004SOD1
29An extended inhibitory context causes skipping of exon 7 of SMN2 in spinal muscular atrophy. (14766219)Singh N.N.... Singh R.N.2004SMN2
30A genetic and phenotypic analysis in Spanish spinal muscular atrophy patients with c.399_402del AGAG, the most frequently found subtle mutation in the SMN1 gene. (12872254)CuscA^ I.... Tizzano E.F.2003SMN1
31High incidence of SMN1 gene deletion in Moroccan adult-onset spinal muscular atrophy patients. (14586604)Bouhouche A.... Chkili T.2003SMN1, NAIP
32Molecular analysis of the spinal muscular atrophy and neuronal apoptosis inhibitory protein genes in Saudi patients with spinal muscular atrophy. (14578966)al-Jumah M.... Al-Uthaim S.2003NAIP
33SMN2 deletion in childhood-onset spinal muscular atrophy. (11977191)Cobben J.M.... de Visser M.2002SMN2
34Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. (11791208)Feldkotter M.... Wirth B.2002SMN1, SMN2
35Genetic testing and risk assessment for spinal muscular atrophy (SMA). (12436240)Ogino S.... Wilson R.B.2002SMN1
36Phenotype and genotype correlation in childhood spinal muscular atrophy. (12001651)Hausmanowa-Petrusewicz I.2001SMN1, NAIP
37Deletion of SMN and NAIP genes in Korean patients with spinal muscular atrophy. (10719817)Shin S.... Park M.H.2000SMN1, NAIP
38Exclusion of Htra2-beta1, an up-regulator of full-length SMN2 transcript, as a modifying gene for spinal muscular atrophy. (11153908)Helmken C.... Wirth B.2000SMN1, SMN2, TRA2B
39Specific sequences of the Sm and Sm-like (Lsm) proteins mediate their interaction with the spinal muscular atrophy disease gene product (SMN). (10851237)Friesen W.J.... Dreyfuss G.2000SMN1, LSM1, SMN2
40Utility and intricacy of molecular diagnosis of spinal muscular atrophy (10565186)Fujii T.... Mitsuyoshi I.1999SMN1, NAIP
41Application of DNA-based tests for diagnosis of spinal muscular atrophy in Saudi Arabia. (11924116)l-Rajeh S.... al-Jumah M.1999NAIP
42High incidence of a survival motor neuron gene/cBCD541 gene ratio of 2 in Japanese parents of spinal muscular atrophy patients: a characteristic background of spinal muscular atrophy in Japan? (9987714)Nishio H.... Sumino K.1999SMN1
43A role for polyproline motifs in the spinal muscular atrophy protein SMN. Profilins bind to and colocalize with smn in nuclear gems. (10608857)Giesemann T.... Jockusch H.1999SMN1
44Molecular diagnosis of spinal muscular atrophy. (9713008)Stewart H.... Kingston H.1998SMN1, NAIP
45The relationship of spinal muscular atrophy to motor neuron disease: investigation of SMN and NAIP gene deletions in sporadic and familial ALS. (9073029)Orrell R.W.... Lane R.J.1997SOD1, SMN1, NAIP
46The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins. (9323129)Liu Q.... Dreyfuss G.1997SMN1, SMN2, SNRPD1
47Identification and characterization of a mouse homolo gue of the spinal muscular atrophy-determining gene, survival motor neuron. (9434164)Bergin A.... Rabin B.A.1997GTF2H2
48Decreased expression of full-length mRNA for cBCD541 does not correlate with spinal muscular atrophy phenotype severity. (9153454)Nishio H.... Sumino K.1997SMN1, SMN2
49Discordant clinical outcome in type III spinal muscular atrophy sibships showing the same deletion pattern. (8887955)Capon F.... Dallapiccola B.1996SMN1, NAIP
50Distribution of androgen receptors in bulbo-spinal muscular atrophy (8200149)Murata K.... Mano Y.1994AR

Expression for genes affiliated with Spinal Muscular Atrophy

Sources:
1BioGPS
See all sources
Expression patterns in normal tissues for genes affiliated with Spinal Muscular Atrophy

Pathways for genes affiliated with Spinal Muscular Atrophy

Sources:
38Reactome, 20KEGG, 3Cell Signaling Technology, 41Thomson Reuters, 10EMD Millipore, 36QIAGEN, 37R&D Systems
See all sources

Compounds for genes affiliated with Spinal Muscular Atrophy

Sources:
32Novoseek , 42Tocris Bioscience, 9DrugBank, 18HMDB, 34PharmGKB
See all sources

Compounds related to spinal muscular atrophy according to GeneDecks:

(show top 50)    (show all 96)
idCompoundScoreTop Affiliating Genes
1nsc3432 9.9SOD1, SMN2, AR
2h2o232 9.8BLZF1, NDUFS4, HSPG2, SNCA, CREB1, APOE
3n acetylcysteine32 9.8SNCA, HDAC9, AR, APOE, TP53
4sp 60012532 42 10.6BIRC2, TP53, CASP3
5ly29400232 9.6STAT5A, BAD, BIRC2, CASP3, HDAC9
610-hydroxycamptothecin32 9.3TOP1, TP53, BCL2L1, BCL2
7antimycin a32 9.3PARP1, BCL2, BCL2L1, NDUFS4, SOD1
8levodopa32 9 9 11.1CHKB, SOD1, PRL, NDUFS4, CREB1, SNCA
94,6-diamidino-2-phenylindole32 9.1PARP1, BCL2, CASP3, TOP1
10beta-lapachone32 9.0TOP1, CASP3, BCL2, PARP1
11ursolic acid32 8.9PARP1, BCL2, CASP3, TOP1
12betulinic acid32 8.9PARP1, BCL2, BCL2L1, CASP3, TOP1
13diallyl disulfide32 8.9PARP1, HDAC9, BCL2, BCL2L1, CASP3
14glutamate32 8.8SNCA, COX5A, NDUFS4, GARS, SLC1A3, MDH1
15sulindac sulfide32 8.8CASP3, BCL2, TP53, COX5A, BCL2L1
16sanguinarine32 8.8CASP3, PARP1, BCL2, BCL2L1
17fludarabine32 9 9 10.8TP53, HDAC9, PARP1, BCL2L1, BIRC2, BCL2
18noxa32 8.7HDAC9, TP53, CASP3, BAD, BCL2L1, BCL2
19mg 13232 42 9.7PARP1, BCL2L1, CASP3, SNCA, STAT5A, HDAC9
20z-vad-fmk32 42 9.6PARP1, TP53, BCL2, BCL2L1, CASP3
21indole-3-carbinol32 8.5CASP3, PARP1, BCL2, TP53, AR, BCL2L1
22zinc32 18 9.5ZNF259, GEMIN2, GTF2H2, CDH2, ATP7A, CHKB
23depsipeptide32 8.5HDAC9, TOP1, TP53, BCL2L1, BCL2, CASP3
24rotenone32 8.4PARP1, SOD1, NDUFS4, SNCA, BAD, CASP3
25suberoylanilide hydroxamic acid32 8.3HDAC9, TP53, CASP3, BCL2L1, PARP1, BCL2
26cytarabine32 34 9 9 11.3CASP3, BCL2L1, STAT5A, TK2, TOP1, BCL2
27flavopiridol32 9 9 10.2PARP1, BCL2, BCL2L1, TOP1, TP53, CASP3
28docetaxel32 34 9 9 11.2CASP3, AR, BCL2L1, BCL2, PARP1, BIRC2
29bortezomib32 9 9 10.1PARP1, BCL2, CASP3, BCL2L1, TP53, TOP1
30gemcitabine32 34 9 9 11.1HDAC9, TK2, PARP1, BCL2, BCL2L1, CASP3
31cysteine32 8.0CHKB, CREB1, COX5A, LSM4, NDUFS4, SLC1A3
32cd 43732 8.0BCL2L1, PARP1, BCL2, TP53, CASP3
33adriamycin32 8.0SOD1, COX5A, TP53, CASP3, BCL2L1, HDAC9
34lactacystin32 8.0TP53, CREB1, PARP1, BCL2, BCL2L1, AR
35phosphatidylserine32 9 9 9.8PARP1, BCL2, BCL2L1, BAD, RNPC3, TOP1
36resveratrol32 9 18 9 10.8TP53, HDAC9, PARP1, BCL2, SOD1, AR
37agarose32 7.8BCL2L1, SNCA, DMD, CASP3, BAD, CHKB
38cisplatin32 34 9 9 10.8NAIP, HDAC9, TOP1, CASP3, GTF2H2, BAD
39etoposide32 42 9 9 10.7BCL2L1, AR, BIRC2, PARP1, HDAC9, TOP1
40curcumin32 7.7CASP3, BIRC2, HDAC9, STAT5A, TP53, CREB1
41actinomycin d32 7.6FBL, APOE, CASP3, CREB1, NOLC1, BLZF1
42egcg32 7.5HSPG2, BCL2L1, BCL2, TP53, PARP1, CASP3
43sb 20358032 42 8.5CREB1, SNCA, CASP3, COX5A, BCL2L1, STAT5A
44arginine32 7.4SOD1, PRL, LSM2, SNCA, RNPC3, SRSF1
45cycloheximide32 7.3TOP1, STAT5A, CREB1, TP53, CASP3, HSPG2
46doxorubicin32 34 9 9 10.2NDUFS4, HDAC9, TOP1, NCAM1, COX5A, TP53
47dexamethasone32 42 34 9 9 11.1BCL2L1, PRL, HSPG2, SP7, COX5A, STAT5A
48vegf32 6.8CHKB, BIRC2, HSPG2, BCL2L1, BCL2, PARP1
49atp32 6.4GARS, HSPG2, GTF2H2, CDH2, ATP7A, CFL1
50serine32 5.1NCAM1, NDUFS4, APOE, STAT5A, LMNA, BLZF1

GO Terms for genes affiliated with Spinal Muscular Atrophy

Sources:
12Gene Ontology
See all sources

Cellular components related to spinal muscular atrophy according to GeneDecks:

(show all 12)
idNameGO IDScoreTop Affiliating Genes
1U7 snRNPGO:00568310.4SNRPB, SNRPD3, SNRPE, SNRPG, SNRPF
2U12-type spliceosomal complexGO:00568910.4RNPC3, SNRPB, SNRPD3, SNRPE, SNRPG, SNRPD2
3ribonucleoprotein complexGO:03052910.2LSM7, LSM5, LSM1, HNRNPR, IGHMBP2, SYNCRIP
4small nuclear ribonucleoprotein complexGO:03053210.0SNRPN, SNRPD1, SNRPF, SNRPD2, SNRPG, SNRPE
5spliceosomal complexGO:00568110.0SNRPD3, SNRPB, SNRPB2, SMN2, SMNDC1, STRAP
6catalytic step 2 spliceosomeGO:0710139.9SNRPB2, LSM2, LSM3, SYNCRIP, SNRPB, SNRPD3
7Cajal bodyGO:0150309.7FBL, DDX20, SMN2, SMNDC1, NOLC1, COIL
8nucleoplasmGO:0056546.9LSM2, KPNB1, TOP1, TGS1, TAF9, SYNCRIP
9nucleolusGO:0057306.6NOLC1, COIL, TOP1, TAF9, TARDBP, DKC1
10cytosolGO:0058294.9SERF2, SNUPN, SNRPD1, SNRPF, SNRPD2, SNRPG
11cytoplasmGO:0057374.9TIAL1, TIA1, KPNB1, LSM1, NOLC1, PLS3
12nucleusGO:0056344.8LSM7, LSM5, LSM3, LSM2, LSM1, RNPC3

Biological processes related to spinal muscular atrophy according to GeneDecks:

(show all 24)
idNameGO IDScoreTop Affiliating Genes
1histone mRNA metabolic processGO:00833410.6SNRPB, SNRPD3, SNRPE, SNRPG, SNRPF
2spliceosomal complex assemblyGO:00024510.6GEMIN6, GEMIN2, SMN2, SNRPE, SNRPG, SNRPD2
3exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decayGO:04392810.6LSM7, LSM6, LSM5, LSM4, LSM3, LSM2
4RNA splicing, via transesterification reactionsGO:00037510.5GEMIN2, LSM1, SMNDC1, TRA2B, KHSRP
5nuclear-transcribed mRNA catabolic process, deadenylation-dependent decayGO:00028810.5LSM7, LSM6, LSM5, LSM4, LSM3, LSM2
6termination of RNA polymerase II transcriptionGO:00636910.4SNRPB, SNRPD3, SNRPE, SNRPG, SNRPF, SRSF1
7lipid storageGO:01991510.4BSCL2, GM2A, HEXA, STAT5A
8mRNA metabolic processGO:01607110.2LSM6, LSM5, LSM4, LSM3, LSM2, LSM1
9spliceosomal snRNP assemblyGO:00038710.1GEMIN6, GEMIN5, GEMIN4, GEMIN2, DDX20, SNUPN
10ncRNA metabolic processGO:03466010.1DDX20, SNUPN, SNRPD1, SNRPF, SNRPD2, SNRPG
11rRNA processingGO:00636410.0GEMIN4, GAR1, DKC1, LSM6, NOLC1, FBL
12nuclear mRNA splicing, via spliceosomeGO:0003989.8HNRNPR, TRA2B, DDX41, SRSF1, SNRPD1, SNRPF
13mRNA processingGO:0063979.8LSM6, TARDBP, STRAP, GEMIN2, LSM5, LSM4
14RNA metabolic processGO:0160709.8KHSRP, DDX20, SNUPN, SNRPD1, SNRPF, GEMIN6
15RNA splicingGO:0083809.7TARDBP, SYNCRIP, STRAP, GEMIN2, LSM6, LSM5
16phospholipid metabolic processGO:0066449.6HADHB, HEXA, SNCA, GM2A, MTM1, CHKB
17transcription from RNA polymerase II promoterGO:0063669.6STAT5A, TARDBP, TAF9, SNRPB, SNRPD3, SNRPE
18cell deathGO:0082199.5DYNC1H1, SMN2, HEXA, DPP6, TARDBP, GARS
19regulation of mitochondrial membrane permeabilityGO:0469029.4TP53, BAD, BCL2L1, BCL2
20negative regulation of neuron apoptotic processGO:0435249.2SOD1, SNCA, MECP2, BCL2L1, BCL2, NAIP
21release of cytochrome c from mitochondriaGO:0018368.9TIMM50, TP53, CASP3, ATP7A, BCL2L1, BCL2
22anti-apoptosisGO:0069168.9SOD1, SNCA, APOE, CFL1, BCL2L1, BCL2
23gene expressionGO:0104678.8KHSRP, LSM3, LSM4, LSM5, LSM6, LSM7
24induction of apoptosis by intracellular signalsGO:0086298.6TP53, CASP3, BAD, BCL2L1, BCL2

Molecular functions related to spinal muscular atrophy according to GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1copper ion bindingGO:0055079.2SOD1, SNCA, TP53, ATP7A, SCO2
2RNA bindingGO:0037238.8KHDRBS1, KHSRP, FBL, IGHMBP2, LSM1, LSM3
3transcription factor bindingGO:0081348.5NOLC1, TP53, IGHMBP2, MECP2, AR, BCL2
4protein bindingGO:0055152.2LSM4, STRAP, SOD1, HDAC9, HADHB, GEMIN2

Sources for Spinal Muscular Atrophy

2CDC
11FMA
18HMDB
19ICD9CM
20KEGG
24MeSH
25MGI
27NCIt
28NDF-RT
31NINDS
32Novoseek
33OMIM
35PubMed
36QIAGEN
43UMLS